SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-025140
Filing Date
2021-10-12
Accepted
2021-10-12 09:15:51
Documents
21
Period of Report
2021-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44270
2 ex2-1_1.htm EX-2.1.1 19289
3 ex3-1_5.htm EX-3.1.5 4193
4 ex99-1.htm EX-99.1 19001
5 ex31-5_001.jpg GRAPHIC 1001099
6 ex31-5_002.jpg GRAPHIC 877821
7 ex31-5_003.jpg GRAPHIC 904080
8 ex31-5_004.jpg GRAPHIC 904556
9 ex99-1_001.jpg GRAPHIC 2393
  Complete submission text file 0001493152-21-025140.txt   5377879

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE vbio-20211012.xsd EX-101.SCH 3025
11 XBRL DEFINITION FILE vbio-20211012_def.xml EX-101.DEF 26190
12 XBRL LABEL FILE vbio-20211012_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE vbio-20211012_pre.xml EX-101.PRE 22359
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3633
Mailing Address 200 PARK AVENUE SUITE 400 CLEVELAND OH 44122
Business Address 200 PARK AVENUE SUITE 400 CLEVELAND OH 44122 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53832 | Film No.: 211317204
SIC: 8731 Services-Commercial Physical & Biological Research